Monday, December 27, 2010
Another retrovirus discovered at University of Alberta - Same controversy as XMRV
In the last year, there has been no shortage of controversy regarding the association of CFS with XMRV and related retroviruses. For several years, Dr. Andrew Mason at the University of Alberta has been studying the association between Primary Biliary Sclerosis, and a Betaretrovirus bearing a close resemblance to Murine Mammary Tumor virus. Much like the CFS studies, the research has been plagued by negative studies. Like the study at Whittemore Peterson Institute, the virus was visualized using electron microscopy. Like in CFS, negative studies have hampered the progress of research.
Thursday, December 9, 2010
Taking on the negative studies
The negative studies - they've sufficed at discrediting good research over the last year - several researchers are finding it difficult to get their XMRV studies published. Rather it seems who you are matters - the CDC, the Wessley group in Britain. The time has come to put politics aside, and put the issue to rest for good. There is a rule in science that in order for a confirmation study to be valid, it means copy exactly!!!
In order to do that, it would mean taking a modest amount of samples, using different methods in the same laboratory. So if we have replica A using the method described by Mikovits et. al, B using the CDC method, C using the Wessely study, and only the first method shows positivity, then contamination can be ruled out.
In order to do that, it would mean taking a modest amount of samples, using different methods in the same laboratory. So if we have replica A using the method described by Mikovits et. al, B using the CDC method, C using the Wessely study, and only the first method shows positivity, then contamination can be ruled out.
Labels:
CDC,
contamination,
Dr.Simon Wessely,
Negative studies,
Politics,
validity
Testimony From a patient
A patient which I will only identify by the name of Ms. X, has provided me with her account of living with CFS, and how as a desperate measure she finally found a doctor that would prescribe her antiretrovirals. Ms. X is 36 years old, and has been living with CFS since age 24. She was once a very active person - having completed the Boston Marathon one year before coming down with CFS. It all started with flu like symptoms she states, but she never fully recover until... By age 25, she would endure malaise on a daily basis - seeing specialist after specialist - two rheumatologists, a sleep specialist, cardiologist. By age 28, she would struggle to work part-time. At age 31, she was admitted to a psychiatric hospital after becoming suicidal as a result of doctors giving her the runaround. It was at this time that she was diagnosed with CFS - and she began graded exercise therapy, which left her even more fatigued.
At the time the Mikovits et. al study came out, she had been unemployed for 3 years. At this time, she began to travel around the country looking for a doctor that would prescribe her antiretrovirals - most doctors were extremely relucatant, until she found one in San Francisco that treated HIV patients early in the epidemic. She was given a two drug combination - Isentress (Raltegravir), and Viread (Tenofovir). Initially, she felt worse (Fever, chills, cough), and almost stopped taking the drugs, but after 21 days began a rapid and sustained improvement. After 3 months, she no longer experienced any musculoskeletal pain, nor any post-exertional malaise, she would return to work full time by 4 months - and currently is capable of exercising 1 hour per day. For her, the monthly cost of the combo treatment comes to a staggering $1500 a month - something she could not afford on her own, nor would any HMO or drug plan want anything to do with it - luckily for help from her family.
At the time the Mikovits et. al study came out, she had been unemployed for 3 years. At this time, she began to travel around the country looking for a doctor that would prescribe her antiretrovirals - most doctors were extremely relucatant, until she found one in San Francisco that treated HIV patients early in the epidemic. She was given a two drug combination - Isentress (Raltegravir), and Viread (Tenofovir). Initially, she felt worse (Fever, chills, cough), and almost stopped taking the drugs, but after 21 days began a rapid and sustained improvement. After 3 months, she no longer experienced any musculoskeletal pain, nor any post-exertional malaise, she would return to work full time by 4 months - and currently is capable of exercising 1 hour per day. For her, the monthly cost of the combo treatment comes to a staggering $1500 a month - something she could not afford on her own, nor would any HMO or drug plan want anything to do with it - luckily for help from her family.
Labels:
Isentress,
post-exertional malaise,
Raltegravir,
Recovery,
Tenofovir,
Viread,
XMRV
EBV and XMRV - a new disease model
An unpublished Spanish study reveals what could possibly unlock the mysteries of CFS. EBV is a common herpesvirus that almost 95% of the population carries by adulthood according to the CDC, however it seldom produces disease. In a percentage of the population it causes infectious mononucleosis, but afterwards remains dormant in immune system cells. It brings the question - Could EBV or another herpesvirus be the key that unlocks the door for XMRV - quite possibly. Once XMRV enters a cell, it could quite conceivably create an immune dysfunction that allows EBV to reactivate at a low level, fuelling a vicious cycle - through EBV producing a gene that downregulates APOBEC3, somewhat like the HIV vif protein does.
Labels:
CFS denialism,
EBV,
Immune dysregulation,
Unpublished study,
XMRV
A new slant on XMRV
Looking at XMRV, and seeing the mention of low copy numbers, how could such a virus cause such nasty disturbances in the immune system. As a scientist, I have to take an analytical point of view - a protein called APOBEC3 has been shown to strongly inhibit retroviral replication. APOBEC3 is however only expressed in certain cells - testicular germ cells most mature blood cells in particular. However it is only expressed in low numbers, or not at all in peripheral tissues. That probably explains why it is found in such low copy numbers in blood cells and seminal plasma. However, that does not mean one should engage in unprotected sex with someone with Fibromyalgia or CFS, even though XMRV is present in low copy numbers, ***IT IS STILL INFECTIOUS***. Tonsilar tissues have been shown to be particularly prone to infection by XMRV.
Rather than simply giving up, it means we have to look elsewhere. By elsewhere means brain, nervous system, lymphatic tissues, bone marrow, tonsils, prostate, spleen, muscle. However, it would not be practical or ethical to biopsy brain or nervous tissue - which leaves the two best choices - bone marrow biopsy which can be done in a doctor's office, and muscle biopsy (in particular from tender points of fibromyalgia patients). Both can be done with a needle, with only slight discomfort.
Rather than simply giving up, it means we have to look elsewhere. By elsewhere means brain, nervous system, lymphatic tissues, bone marrow, tonsils, prostate, spleen, muscle. However, it would not be practical or ethical to biopsy brain or nervous tissue - which leaves the two best choices - bone marrow biopsy which can be done in a doctor's office, and muscle biopsy (in particular from tender points of fibromyalgia patients). Both can be done with a needle, with only slight discomfort.
Labels:
APOBEC3,
bone marrow biopsy,
Fibromyalgia,
Low Copy Numbers,
Muscle Biopsy,
Tonsils,
XMRV
I've returned
After a long hiatus, I'm back. The last year has been rather uneventful for me - I've had opportunities to pursue research, but unfortunately with the turn of events, I found that I could not undertake research that was against my beliefs. Science is fraught with politics, and they say the best scientists are those that are independent thinkers - Albert Einstein's theory of relativity was laughed at at first... Same situation is happening with Judy Mikovits. But meanwhile, I've taken on consulting work for a couple of biotech companies on contract. But I am as passionate as ever about CFS and XMRV.
Subscribe to:
Posts (Atom)